Top Markets
Coin of the day
HealthBeacon plc HealthBeacon plc

HealthBeacon plc

HBCNF
Classifica tra le azioni #33072
HealthBeacon plc functions as a digital therapeutics firm that specializes in... HealthBeacon plc functions as a digital therapeutics firm that specializes in developing technologies to support individuals in overseeing their self-administered injectable medications from the comfort of their homes. Its services are available across Europe, the United States, and Ireland. The company's flagship offering is an injection care management system, meticulously designed to monitor and improve patient compliance and consistent usage of prescribed medication regimens. This is achieved by providing a comprehensive set of tools, which include automated treatment reminders, secure and environmentally responsible sharps disposal containers, patient education resources, and advanced data analysis driven by artificial intelligence. HealthBeacon plc further expands its business by offering these innovative medical adherence devices and injection care management systems through both outright sales and leasing arrangements. The company was founded in 2013 and maintains its headquarters in Dublin, Ireland.
Prezzo delle azioni
$0.5
Ultima sincronizzazione: 2024-01-30
Capitalizzazione di mercato
$8.45M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
IE
Scambia HealthBeacon plc (HBCNF)

Categoria

Utile per HealthBeacon plc (HBCNF)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di HealthBeacon plc, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di HealthBeacon plc dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$2.04B -
US
$222.34M -
AU
$295.53M -
US
$-259.89M -
US
- -
US